Lyme Disease Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight

AI Briefing

• – Lyme Disease pipeline comprises over 50+ therapies in various stages of development.
• – The US FDA has updated its guidelines for Lyme disease treatment, emphasizing the need for long-term therapies and combination treatments.
• – Several innovative therapies, including monoclonal antibodies and gene therapies, are being explored for Lyme disease treatment, with several clinical trials underway.